7.70 USD
↘ 0.03 (0.39%)PRE MARKET (AS OF 04:12 AM EDT)
Aura Biosciences, Inc. Common Stock
AURANASDAQ • USD
Market: OPEN
AURA is currently priced at $7.70. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, AURA appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Aug 26, 2026.
Open?$7.70
High?$7.70
Low?$7.70
Prev. Close?$7.73
Volume?17
Avg. Volume?660.2K
VWAP?$7.70
Rel. Volume?0.00x
Bid / Ask
Bid?$5.96 × 100
Ask?$9.23 × 100
Spread?$3.27
Midpoint?$7.60
Valuation & Ratios
Market Cap?801.6M
Shares Out?103.7M
Float?90.3M
Float %?87.3%
P/E Ratio?N/A
P/B Ratio?2.54
EPS?-$1.26
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
Themes
Employees
113
Market Cap
811.0M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-10-29
Address
80 GUEST STREET
BOSTON, MA 02135
Phone: (617)500-8864
BOSTON, MA 02135
Phone: (617)500-8864
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?65
Short Sent.?63
Piotroski F-Score?0/9Weak
Altman Z-Score?12.31Safe
Confidence?48%Low
Short InterestHigh
Short % of Float?6.82%Elevated
Short Interest?6.2M
Days to Cover?9.9
Free Float90.3M
Avg Daily Volume622.1K
Settlement Date2026-08-14
Financial Health
Current Ratio?16.82Strong
Quick Ratio?16.82Strong
Cash Ratio?3.47Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.54CHEAP▾
Peers100
S&P64
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-5.4CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-41.6%WEAK▾
S&P3
ROA?-37.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-103351000
Enterprise Value?$733.8M
Fundamentals ratios updated end of day